摘要 目的：觀察半夏泻心汤治疗结直肠癌术后肝脾不和证的临床疗效。方法：选取郑州市中医院2014年9月至2016年6月期间收治的140例结直肠癌术后肝脾不和证患者为研究对象，按照随机数表法分为对照组( n =70)和观察组( n =70)。对照组采用常规内科治疗，观察组在对照组基础上采用半夏泻心汤治疗。比较2组治疗前后临床症状、生命质量、血清癌胚抗原(Carcino Embryonic Antigen，CEA)水平，并评价2组临床疗效及安全性。结果：观察组临床疗效总有率为90.00%(63/70)，明显高于对照组71.43%(50/70)，差异有统计学意义( P , http://www.100md.com
 关键词 半夏泻心汤；结直肠癌术；肝脾不和证；临床疗效；CEA水平；生命质量

 Clinical Study on Banxia Xiexin Decoction in Treatment of Disharmony between Liver and Spleen after Colorectal Cancer Surgery

 Li Yingjie， Qiu Shuguang， Liang Jun

 (Zhengzhou Hospital of Traditional Chinese Medicine， Zhengzhou 450007， China)

 Abstract Objective： To observe the clinical efficacy of Banxia Xiexin Decoction in treatment of disharmony between liver and spleen after colorectal cancer surgery. Methods： A total of 140 patients with disharmony between liver and spleen after colorectal cancer surgery admitted into the hospital from September 2014 to June 2016 were selected as research subjects and were divided into control group ( n =70) and research group ( n =70) by random number table. Patients in the control group took conventional medical treatment， while patients in the research group additionally took Banxia Xiexin decoction on the basis of treatment for the control group. The clinical symptoms， survival quality and carcino embryonic antigen (CEA) level of the two groups before and after the treatment were compared. The clinical efficacy and safety of the two groups were evaluated. Results： The total effective rate of the research group was 90.00% (63/70)， which was significantly higher than 71.43% (50/70) of the control group ( P , 百拇医药(李应杰 邱曙光 梁君) 第 1 2 3 4 页 下一页

 参见：首页 > 中医药 > 中医专业 > 中医方剂 > 常用方剂 > 和解剂 > 调和肠胃 > 半夏泻心汤
 百拇医药网 http://www.100md.com/html/paper/1673-7202/2017/07/09.htm